Corcepttherapeutics
Senior Medical Director, Oncology
Redwood City, California, United States. Posted 8 months ago
The role
The Senior Medical Director, Oncology will design and implement Phase I to III clinical studies. This person will provide scientific oversight, medical oversight, and safety monitoring for therapeutic programs.
What you will do
- Design and implement Phase I to III clinical studies
- Develop and participate in the writing and review of protocols, investigator brochures, study reports and other clinical and regulatory documents
- Provide scientific oversight for Company operational staff, CROs, and clinical trial sites
- Act as a clinical subject matter expert for Company team members and external contacts
- Establish and approve scientific methods for design and implementation of clinical protocols, data collection systems and final reports
- Provide medical oversight and safety monitoring for ongoing clinical trials
- Play a key role in the analysis, interpretation and delivery of high-quality clinical data
- Interact with principal investigators and opinion leaders to facilitate clinical trials research
- Participate in regulatory discussion and activities including filing of INDs, CTXs, NDA/MAAs
- Provide training and ongoing input to clinical team members on medical and scientific issues
Required qualifications
- Applicants must be currently authorized to work in the United States on a full-time basis
Nice to have
- Strong clinical and scientific knowledge
- Excellent communicator with proven leadership skills
- Ability to interact in a cross functional environment
- Comfortable in a fast-paced and nimble small company environment
- MD, board-certified (or eligible)
- Expertise in Oncology
- Strong track record of scientific activity demonstrated by publications in top tier journals
- At least 6+ years of relevant clinical development experience
- Relevant basic and/or clinical research experience in academic settings
About the company
Corcept is focused on the science of cortisol. The company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists.